6-[(3-chloro-4-fluorophenyl)methyl]-1-(oxolan-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;4-methylidene-1-(oxan-4-yl)-6-(pyrimidin-2-ylmethyl)-5H-pyrazolo[5,4-b]pyridine;1-(oxolan-3-yl)-6-[[2-(trifluoromethoxy)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one
C50H48ClF4N13O6 — CID 137099655
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[(3-chloro-4-fluorophenyl)methyl]-1-(oxolan-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;4-methylidene-1-(oxan-4-yl)-6-(pyrimidin-2-ylmethyl)-5H-pyrazolo[5,4-b]pyridine;1-(oxolan-3-yl)-6-[[2-(trifluoromethoxy)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one
6-[(3-chloro-4-fluorophenyl)methyl]-1-(oxolan-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;4-methylidene-1-(oxan-4-yl)-6-(pyrimidin-2-ylmethyl)-5H-pyrazolo[5,4-b]pyridine;1-(oxolan-3-yl)-6-[[2-(trifluoromethoxy)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one (PubChem CID 137099655) has the molecular formula C50H48ClF4N13O6 and a molecular weight of 1038.46 g/mol. Its IUPAC name is 6-[(3-chloro-4-fluorophenyl)methyl]-1-(oxolan-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;4-methylidene-1-(oxan-4-yl)-6-(pyrimidin-2-ylmethyl)-5H-pyrazolo[5,4-b]pyridine;1-(oxolan-3-yl)-6-[[2-(trifluoromethoxy)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one.
Molecular Properties
| Compound Name | 6-[(3-chloro-4-fluorophenyl)methyl]-1-(oxolan-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;4-methylidene-1-(oxan-4-yl)-6-(pyrimidin-2-ylmethyl)-5H-pyrazolo[5,4-b]pyridine;1-(oxolan-3-yl)-6-[[2-(trifluoromethoxy)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one |
|---|---|
| PubChem CID | 137099655 |
| Molecular Formula | C50H48ClF4N13O6 |
| Molecular Weight | 1038.46 g/mol |
| Exact Mass | 1037.35 |
| IUPAC Name | 6-[(3-chloro-4-fluorophenyl)methyl]-1-(oxolan-3-yl)-5H-pyrazolo[5,4-d]pyrimidin-4-one;4-methylidene-1-(oxan-4-yl)-6-(pyrimidin-2-ylmethyl)-5H-pyrazolo[5,4-b]pyridine;1-(oxolan-3-yl)-6-[[2-(trifluoromethoxy)phenyl]methyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one |
| SMILES | C=C1CC(Cc2ncccn2)=Nc2c1cnn2C1CCOCC1.O=c1[nH]c(Cc2ccc(F)c(Cl)c2)nc2c1cnn2C1CCOC1.O=c1[nH]c(Cc2ccccc2OC(F)(F)F)nc2c1cnn2C1CCOC1 |
| InChI | InChI=1S/C17H15F3N4O3.C17H19N5O.C16H14ClFN4O2/c18-17(19,20)27-13-4-2-1-3-10(13)7-14-22-15-12(16(25)23-14)8-21-24(15)11-5-6-26-9-11;1-12-9-13(10-16-18-5-2-6-19-16)21-17-15(12)11-20-22(17)14-3-7-23-8-4-14;17-12-5-9(1-2-13(12)18)6-14-20-15-11(16(23)21-14)7-19-22(15)10-3-4-24-8-10/h1-4,8,11H,5-7,9H2,(H,22,23,25);2,5-6,11,14H,1,3-4,7-10H2;1-2,5,7,10H,3-4,6,8H2,(H,20,21,23) |
| InChIKey | PXPJDXBRPVMYRU-UHFFFAOYSA-N |
| XLogP | 7.79 |
| TPSA | 220.02 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 74 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1038.46 |
| LogP ≤ 5 | 7.79 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137099655 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.